The court tells Directorate General of Drug Administration (DGDA) to implement the directive
The High Court has directed concerned government offices to ensure the rapid supply of life-saving drugs that are currently unavailable in the market.
The court asked the Directorate General of Drug Administration (DGDA) to implement the directive.
Following a writ petition filed by Supreme Court lawyer Sirajul Islam on January 2020, the High Court bench of Justice Md Khasruzzaman and Justice Md Mahmud Hasan Talukder issued the directive and rule on Sunday.
The petitioner moved the High Court as he could not find the Delipit-300 drug for liver and diabetic diseases in the market. He later sent legal notices to concerned departments, including the DGDA.
Advocate Parveen Akhter represented the petitioner while Deputy Attorney General Bipul Bagmar argued for the state.
Among others, the secretary of health ministry, the head of the National Drug Advisory Council, the Bangladesh Association of Pharmaceutical Industries, the managing director of Square Hospitals, the director general of the DGDA were made respondents to the writ.